Overview A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris Status: Completed Trial end date: 2011-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the safety and efficacy of IDP-107 versus placebo in treating patients with acne vulgaris. Phase: Phase 2 Details Lead Sponsor: Dow Pharmaceutical Sciences